Clinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Therapeutic Effect and Safety of LPTAT in Children With Myopia
NCT05529056 is registered in ClinicalTrials.gov with LitePharmTech Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Therapeutic Effect and Safety of LPTAT in Children With Myopia
- Lead sponsor
- LitePharmTech Co., Ltd.
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- May 25, 2022
- Completion date
- December 31, 2023
- Enrollment
- 472 (estimated)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
children, myopia